Mesothelin and MUC16 (CA125) are antigen-targets for CAR T-cell therapy in primary and metastatic lung adenocarcinoma Meeting Abstract


Authors: Eguchi, T.; Ujiie, H.; Morello, A.; Kadota, K.; Buitrago, D. H.; Woo, K.; Jones, D. R.; Travis, W. D.; Sadelain, M.; Adusumilli, P. S.
Abstract Title: Mesothelin and MUC16 (CA125) are antigen-targets for CAR T-cell therapy in primary and metastatic lung adenocarcinoma
Meeting Title: 16th World Conference on Lung Cancer (WCLC)
Keywords: immunotherapy; mesothelin; muc16
Journal Title: Journal of Thoracic Oncology
Volume: 10
Issue: 9 Suppl. 2
Meeting Dates: 2015 Sep 6-9
Meeting Location: Denver, CO
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2015-09-01
Start Page: S229
Language: English
ACCESSION: WOS:000370365100373
PROVIDER: wos
PUBMED: 26710300
DOI: 10.1016/S1556-0864(16)30010-7
Notes: Meeting Abstract: ORAL28.05 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. William D Travis
    749 Travis
  2. Michel W J Sadelain
    584 Sadelain
  3. Hideki Ujiie
    11 Ujiie
  4. David Randolph Jones
    418 Jones
  5. Kaitlin Marie Woo
    101 Woo
  6. Aurore Ornella Lauriane Morello
    14 Morello
  7. Takashi   Eguchi
    71 Eguchi